Drug
PG-760564 clinical trials
Also written PG-760564.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How studies write it
Studies that test it under each name
Development codes
- PG-760564
- 3
Studies by the year they started
3 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses PG-760564 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 DaysCompletedPhase 1Procter and GambleNCT00791388Written as PG-760564
- Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving MethotrexateCompletedPhase 2Procter and GambleNCT00369928Written as PG-760564
- Study to Evaluate Potential Food EffectsCompletedPhase 1Procter and GambleNCT00791817Written as PG-760564